Discover more from FarmaKology’s Substack
FarmaKology Newsletter - Issue #10
Avails Medical, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and health-care associated infections. As repeatedly stated by experts around the world, antimicrobial resistance could spell the end of modern medicine.
Once rejected by the FDA, Pfizer’s tafamidis is back and ready to disrupt a rare disease field only recently tapped by Alnylam and Ionis. And the pharma giant's entrant, now dubbed Vyndaqel, comes with a much lower price tag.
Twelve weeks after filing its supplemental Biologics License Application, Genentech’s Kadcyla secured approval from the U.S. Food and Drug Administration (FDA) for a second breast cancer indication.
Sun Pharmaceutical Industries is scouting for a partner in China to help it win a larger piece of the worlds second-largest drug market, where the government is on a mission to drive down healthcare costs.
Takeda has opening a new research facility in San Diego, CA. The 165,000-square-foot facility is home to more than 250 employees focused on leveraging specialized drug discovery technologies and advancing discovery research in gastroenterology and neuroscience.
Research & Study
Listen to 396: The Use Of Methylene Blue For The Treatment Of Refractory Anaphylaxis Without Hypotension and 299 other episodes by The Elective Rotation - A Critical Care Pharmacy Podcast. No signup or install required.